Select a community
All Communities
Home > Community Treatment Reports > Endep (amitriptyline) Treatment Report
What is Endep?

Endep is an international brand name for amitriptyline. It is a tricyclic antidepressant approved for the treatment of depression. Off label amitripyline is used for certain chronic and neuropathic (nerve) pain and for prevention of migraine headaches.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 3 0
Migraine Headaches 2 1
Pain 1 0
saliva control 1 1
Nerve pain (neuropathic pain) 1 0
Depression 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
2 100%
None
0 0%

Most commonly reported side effects

headaches at first
1 50%
Weight gain
1 50%
Bloating
1 50%
Blurred Vision
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  10 mg daily 20 mg daily 25 mg daily 40 mg daily 100 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Endep (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 33% Did not seem to work: 33%
Side effects too severe
1 33% Side effects too severe: 33%
Not indicated
1 33% Not indicated: 33%

See all 3 patients who’ve stopped taking Endep

Currently Taking Endep

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
2
1
1
1

Stopped Taking Endep

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
1
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.